Continuous apomorphine infusion (CAI) and neuropsychiatric disorders in patients with advanced Parkinson's disease: A follow-up of two years

Archives of Gerontology and Geriatrics

Volumn 38, Issue SUPPL., 2004, Pages 291-296

  Morgante, L ^a   Basile, G ^a   Epifanio, A ^a   Spina, E ^a   Antonini, A ^b   Stocchi, F ^c   Di Rosa, E ^a   Martino, G ^a   Marconi, R ^d   La Spina, P ^a   Nicita Mauro, V ^a   Di Rosa, A E ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b 'Giorgio Spagnol' Serv Clin N   (Italy)

^c IRCCS NEUROMED   (Italy)

^d MISERICORDIA HOSPITAL   (Italy)

Author keywords

Continuous apomorphine infusion; Neuropsychiatric impairments; Parkinson's disease

Indexed keywords

ANTIEMETIC AGENT; ANTIPARKINSON AGENT; APOMORPHINE; DOMPERIDONE; LEVODOPA; STEROID; DOPAMINE RECEPTOR STIMULATING AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITIVE DEFECT; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FOLLOW UP; HUMAN; MENTAL DISEASE; MOOD; MOTOR DYSFUNCTION; NAUSEA; NEUROPSYCHIATRY; NEUROPSYCHOLOGICAL TEST; PARKINSON DISEASE; PRIORITY JOURNAL; PRURITUS; SIDE EFFECT; SINGLE BLIND PROCEDURE; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; BRAIN; DEPRESSION; DRUG ADMINISTRATION; FEMALE; HOSPITALIZATION; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE;

ANTIEMETICS; APOMORPHINE; BRAIN; COGNITION DISORDERS; DEPRESSION; DOMPERIDONE; DOPAMINE AGONISTS; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; SINGLE-BLIND METHOD;

EID: 3042647039     PISSN: 01674943     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.archger.2004.04.039     Document Type: Article

References (16)

1. Beck, A.T., Ward, C.N., Mendelson, M., Mock, J.F. and Erbanga, J.K. (1961): An inventory for measuring depression. Arch. Gen. Psychiatry, 4, 561-571.
2. Berney, A., Vingerhoets, F., Perrin, A., Guex, P., Villermure, J.G., Burkhard, P.R., Benkelfat, C. and Ghika, J. (2002): Effect on mood of subthalamic DBS for Parkinson's disease: a consecutive series of 24 patients. Neurology, 59, 1298-1299.
3. Di Rosa, A.E., Epifanio, A., Antonini, A., Stocchi, F., Martino, G., Di Blasi, L., Tetto, A., Basile, G., Imbesi, D., La Spina, P., Di Raimondo, G. and Morgante, L. (2003): Continuous apomorphine infusion and neuropsychiatric disorders: a controlled study in patients with advanced Parkinson's disease. Neurol. Sci., 24, 174-175.
4. Folstein, M.F., Folstein, S.E. and McHugh, P.R. (1975): Mini-Mental State. A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res., 12, 189-198.
5. Gelb, D.J., Olivier, E. and Gilman, S. (1999): Diagnostic criteria for Parkinson's disease. Arch. Neurol., 56, 33-39.
6. Giovannoni, G., O'Sullivan, J.D., Tarner, K., Manson, A.J. and Lees, A.J. (2000): Hedonistic homeostatic dysregulation in patients with Parkinson's disease on dopamine replacement therapies. J. Neurol. Neurosurg. Psychiatry, 68, 423-428.
7. Guy, W. (1976): Abnormal involuntary movement scale. In: US Department of Health, Education and Welfare: Assessment Manual for Psychopharmacology. Washington, DC, pp.: 534-537.
8. Hoehn, M.M. and Yahr, M.D. (1967): Parkinsonism: onset, progression and mortality. Neurology, 17, 427-442.
9. Limousin, P., Krack, P., Pollak, P., Benazzous, A., Ardouin, C., Hoffman, D. and Benabid, A.L. (1998): Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease. New Engl. J. Med., 339, 1105-1111.
10. Overall, J.E. and Gurham., D.R. (1962): The brief psychiatric rating scale. Psychol. Rep., 10, 799-813.
11. Pietz, K., Hagell, P. and Odin, P. (1998): Subcutaneous apomorphine in late stage Parkinson's disease: a long term follow-up. J. Neurol. Neurosurg. Psychiatry, 65, 709-716.
12. Poewe, W.H. and Wenning, G.K. (1998): The natural history of Parkinson's disease. Ann. Neurol., 44 (Suppl.1), S1-S9.
13. Poewe, W., Kleedorfer, B., Wagner, M. and Schelosky, L. (1991): Continuous subcutaneous apomorphine infusions for fluctuating Parkinson's disease. Long-term experience in 20 patients. Neurology, 41, 172-173.
14. Poewe, W., Kleedorfer, B., Wagner, M., Bosch, S. and Schelosky, L. (1993): Continuous subcutaneous apomorphine infusion for fluctuating Parkinson's disease. Long-term follow-up in 18 patients. Adv. Neurol., 60, 656-659.
15. Pollak, P., Champay, A.S., Hommel, M., Perret, J.E. and Benabid, A. (1989): Subcutaneous apomorphine in Parkinson's disease. J. Neurol. Neurosurg. Psychiatry, 52, 544.
16. Stocchi, F., Bramante, L., Monge, A., Viselli, F., Baronti, F., Stefano, E. and Ruggieri, S. (1993): Apomorphine and Lisuride infusion. A comparative chronic study. Adv. Neurol., 60, 653-655.